Science Videos

from AP, Reuters, AFP, and other news services

FDA-Approved Sleeping Pill Not Compared To Other Drugs

Date:
August 14, 2014
Source:
Newsy / Powered by NewsLook.com
Summary:
The FDA has approved Belsomra, a new kind of sleep aid that could help people fall asleep faster and stay asleep longer. Video provided by Newsy


Related Videos

last updated on 2014-10-24 at 5:29 pm EDT

Medical Marijuana Debate: Light Up or Pop a Pill?

Medical Marijuana Debate: Light Up or Pop a Pill?

Ivanhoe (Feb. 3, 2014) — Medical marijuana is now legal in 20 states, plus our nation’s capital. But under federal law, only FDA approved medications can be prescribed; marijuana is not one of them. So, is it safer than prescription drugs? Is marijuana really medicine? Find out the latest on this controversial topic.
Powered by NewsLook.com
Doping the Brain: The Dangerous Side Effects of 'Smart Drugs'

Doping the Brain: The Dangerous Side Effects of 'Smart Drugs'

Deutsche Welle (Oct. 13, 2013) — Just pop a pill and you're suddenly at the top of your game - that's a dream fueled by the widespread global abuse of drugs that claim to enhance mental performance.Klaus Lieb, director of the clinic for psychiatry and psychotherapy at the University of Mainz, has found that around 20 percent of students and surgeons in Germany have experimented with so-called brain doping. But do these pills really help? And what about their side effects? For a study, Lieb made 40 chess players face off against a computer - with the help of ritalin, modafilin and a placebo.
Powered by NewsLook.com
FDA Approves 'Argus II' a Bionic Eye for the Blind

FDA Approves 'Argus II' a Bionic Eye for the Blind

Newsy (Feb. 15, 2013) — The FDA has approved technology that could potentially help the visually impaired see again. Made by Second Sight the device is mounted to glasses.
Powered by NewsLook.com
Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

MultiVu (Aug. 21, 2012) — Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins